Publications by authors named "Urte Gayko"

Claim this Profile
C
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia.
Alessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, Urte Gayko, Santosh Putta

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies.
Urte Gayko, Mann Fung, Fong Clow, Steven Sun, Elizabeth Faust

Ann N Y Acad Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status.
Alessandra Cesano, Santosh Putta, David B Rosen, Aileen C Cohen, Urte Gayko

PLoS One· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group.
Norman J Lacayo, Todd A Alonzo, Urte Gayko, David B Rosen, Matt Westfall

Br J Haematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts.
Alessandra Cesano, David B Rosen, Pat O'Meara, Santosh Putta, Urte Gayko

Cytometry B Clin Cytom· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).
David B Rosen, Mark D Minden, Steven M Kornblau, Aileen Cohen, Urte Gayko

PLoS One· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapy.
Steven M Kornblau, Mark D Minden, David B Rosen, Santosh Putta, Aileen Cohen, Urte Gayko

Clin Cancer Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
John R Zalcberg, Lee S Rosen, Ehtesham Abdi, Ian D Davis, John Gutheil, Urte Gayko

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
Lee S Rosen, Ehtesham Abdi, Ian D Davis, John Gutheil, Frederick M Schnell, Urte Gayko

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.
John P Leonard, Morton Coleman, Jamie C Ketas, Amy Chadburn, Richard Furman, Urte Gayko

Clin Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temperature-sensitive control of protein activity by conditionally splicing inteins.
Martin P Zeidler, Change Tan, Yohanns Bellaiche, Sara Cherry, Sabine Häder, Urte Gayko

Nat Biotechnol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.
John P Leonard, Morton Coleman, Jamie C Ketas, Amy Chadburn, Scott Ely, Urte Gayko

J Clin Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD22 as a target of passive immunotherapy.
Alessandra Cesano, Urte Gayko

Semin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis